Health Care
Oman’s Health Ministry Launches Oxford-AstraZeneca Vaccination Campaign
Muscat: The Sultanate’s Ministry of Health today launched a campaign targeting a new segment of the society as part of its COVID-19 national immunization drive using the Oxford-AstraZeneca vaccine.
The campaign targets people aged 65 and above across all governorates of the Sultanate, irrespective of whether they are ‘healthy’ or not. The vaccine will be given at designated immunization centres.
Also Read: The Sultanate Receives 100,000 Doses Of Oxford AstraZeneca Vaccine
The two-dose vaccine will be administered in intervals of four weeks.
It should be noted that people who have already received the first dose of Pfizer-bioNTech will not be given the new vaccine. The Oman News Agency confirmed that the Ministry of Health will announce the date of applying for the second dose of Pfizer-BioNTech later.
The Minister also stated that the preliminary indication is that the vaccines are effective against the new strains of the virus.
Speaking to the media in a press conference, the minister said: “The Serum Institute of India (SII) is one of the largest vaccine factories in the world.
The Minister also confirmed that the step to obtain the vaccine reinforces the global efforts aimed at overcoming the Coronavirus pandemic and make vaccines available among all people of the world.
-
Economy2 months agoOMIFCO IPO: Price, Dividends, Subscription Dates and Listing – Here’s Everything You Need to Know
-
Magazines2 months agoOER May 2026 Edition: The Digital Copy
-
News4 weeks agoINVESTIGATION: Why Nokia Could Matter More in the Quantum Age Than It Ever Did in Mobile
-
Investment1 month agoWhy Are Tech Stocks Rising Again – And Is It Too Late To Invest In Them?
-
News1 month agoINVESTIGATION: Is AI in a Bubble? Inside the Trillion-Dollar Question Reshaping Global Markets
-
Magazines2 months agoSignature Oman: May 2026 Edition
-
Banking & Finance1 month agoSohar Islamic Launches Exclusive Infinite Credit Card for HNWIs in Oman
-
Economy1 month agoOMIFCO Successfully Completes Bookbuilding & Sets Final IPO Offer Price
